Mookkan Prabakaran Selected Research

Mookkan Prabakaran Research Topics

19	Human Influenza (Influenza) 10/2019 - 01/2009
12	Infections 01/2023 - 10/2008
4	Influenza in Birds (Avian Flu) 10/2013 - 02/2008
3	Virus Diseases (Viral Diseases) 01/2023 - 12/2017
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2018
1	Necrosis 01/2023
1	COVID-19 01/2022
1	Central Nervous System Infections (Central Nervous System Infection) 02/2016

14	VaccinesIBA 01/2023 - 10/2008
5	Hemagglutinins (Hemagglutinin)IBA 09/2014 - 03/2009
4	Monoclonal AntibodiesIBA 10/2013 - 01/2009
3	AntigensIBA 01/2018 - 02/2008
3	EpitopesIBA 12/2017 - 01/2009
2	RNA (Ribonucleic Acid)IBA 10/2019 - 01/2019
2	Viral RNAIBA 01/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 02/2016 - 01/2015
2	AntibodiesIBA 01/2011 - 01/2009
2	Peptides (Polypeptides)IBA 01/2011 - 03/2009
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2022
1	Viral VaccinesIBA 01/2022
1	NucleotidesIBA 01/2019
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2019
1	Peptide Nucleic AcidsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 12/2017
1	Staphylococcal Protein A (Protein A)IBA 02/2016
1	Complementary DNA (cDNA)IBA 01/2015
1	Inactivated VaccinesIBA 09/2011
1	MicellesIBA 05/2010
1	Phosphatidylcholines (Phosphatidylcholine)IBA 05/2010
1	Therapeutic UsesIBA 03/2009
1	Immune Sera (Antisera)IBA 01/2009

4	Therapeutics 01/2019 - 03/2009
2	Intranasal Administration 09/2014 - 10/2013